The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the gist of it was that on some what appear to be subjective measurements of quality of life there was an improvement in patients with ALS taking this very high dose of nicotine oh my driver's side with pterostilbene versus those taking a placebo and what they measured some cardiac function as well I think they measured one pulmonary function called forced vital capacity
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
of the functional scales of progression uh the answer appeared that yes this compound of nicotinamide and terban actually delayed prog agression um by a short period of time for these patients